Dr. Yevgeniya Gartshteyn, MD

Dr. Gartshteyn practices at Core Surgery Center in Lyndhurst, New Jersey.

Dr. Gartshteyn's NPI, 1962794909, was assigned on May 10, 2011. Dr. Gartshteyn graduated from New York University School of Medicine in 2011. Dr. Gartshteyn holds New York license 268394.

Dr. Gartshteyn's primary practice is Core Surgery Center, at 256 Stuyvesant Avenue, Lyndhurst, NJ 07071. The practice phone is (201) 905-1113.

Dr. Gartshteyn's primary practice is Core Surgery Center in Lyndhurst, New Jersey. Dr. Gartshteyn is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is CORE Medical & Wellness. Dmand AI also links Dr. Gartshteyn to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gartshteyn practices, 5 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Gartshteyn's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Gartshteyn is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Gartshteyn's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint pain, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Gartshteyn treats.

CMS data shows 466 Medicare services from Dr. Gartshteyn across 6 procedure codes in 2024, for 120 Medicare patients. Medicare paid $39,327 for them. Every service was in an office.

CMS counts 120 Medicare patients who saw Dr. Gartshteyn in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have arthritis, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gartshteyn's median patient age at 60, with 76% women.

In 2024, Dr. Gartshteyn wrote 1,281 Medicare Part D claims for 169 patients. 83% of them were for generic drugs. CMS names the drug for 1,047 of them, across 28 drugs with 11 or more claims each, at $740,387 in total drug cost. In 2023, CMS named 1,043 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gartshteyn for performance year 2024, reported through an alternative payment model (APM). Dr. Gartshteyn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gartshteyn as offering telehealth.

Dmand AI links 30 papers to Dr. Gartshteyn, published from 2011 to 2025. 2020 was the busiest year, with 6. The most frequent topics are Lupus Erythematosus, Systemic, Arthritis and Autoimmune Diseases. Dr. Gartshteyn has published most often in Lupus Sci Med. Dr. Gartshteyn's most frequent co-authors are Anca D. Askanase, MD, Adam Mor, MD and Laura Berenice Geraldino Pardilla, MD.

CMS Open Payments shows 13 general payments to Dr. Gartshteyn from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. GlaxoSmithKline, LLC. paid the most, $222.

Dr. Gartshteyn graduated from New York University School of Medicine in 2011.

Dr. Gartshteyn is in network with 11 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.